Press Releases | Sutro Biopharma, Inc.

Sutro Biopharma Secures $36.5 Million in Series C Financing

Sutro Biopharma Secures $36.5 Million in Series C Financing South San Francisco, CA Nov. 17, 2010 – Sutro Biopharma today announced that the company has secured $36.5 million in Series C financing. This financing will support the company’s ongoing...

Sutro Biopharma Announces Additions to Board of Directors and Senior Management Team

Press Releases

Sutro Biopharma Announces Additions to Board of Directors and Senior Management Team South San Francisco, CA (August 20, 2009) Sutro Biopharma, Inc., the leader in open cell-free synthesis (OCFS) for the discovery and production of proteins, today announced several...

Sutro Biopharma Adds to Extensive IP Portfolio with Two Newly Issued Patents and Two Patent Grant Notices — Covers the Only Cell-Free Synthesis Platform Applicable to Protein Discovery Through Production —

Press Releases

Sutro Biopharma Adds to Extensive IP Portfolio with Two Newly Issued Patents and Two Patent Grant Notices — Covers the Only Cell-Free Synthesis Platform Applicable to Protein Discovery Through Production — South San Francisco, CA (June 9, 2009) Sutro...

Sutro Biopharma Hits Major Technical Milestone, Reaching 100 Liter Scale for the Company’s Open Cell-free Protein Synthesis Technology – Milestone Triggers $15 Million Series B Financing

Press Releases

Sutro Biopharma Hits Major Technical Milestone, Reaching 100 Liter Scale for the Company’s Open Cell-free Protein Synthesis Technology – Milestone Triggers $15 Million Series B Financing South San Francisco, CA (March 30, 2009) Sutro Biopharma, Inc., a pioneer...

William J. Newell Named Chief Executive Officer of Sutro Biopharma – Former CEO Daniel S. Gold, Ph.D. Becomes President and Chief Operating Officer – Company Notes Name Change from Fundamental Applied Biology and Relocation to South San Francisco

Press Releases

William J. Newell Named Chief Executive Officer of Sutro Biopharma – Former CEO Daniel S. Gold, Ph.D. Becomes President and Chief Operating Officer – Company Notes Name Change from Fundamental Applied Biology and Relocation to South San Francisco South San...

Next Entries »